...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Accelerated approval

,,,the Zenith AGMs seem to echo the Groundhog Day movie theme,,,,we relive the same old status each Fall,,,,,,,we are broke,,need cash,,,we are not going public,,,,talking to prospective partners,,,,,,,,,and well,,,,,,,just a lot of talking,,,,,,,,

 

 

 

Share
New Message
Please login to post a reply